Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade.

Chon, Hong Jae

Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research 03 2019 - 1612-1623 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1557-3265

10.1158/1078-0432.CCR-18-1932 doi


Animals
Antineoplastic Agents, Immunological--pharmacology
Biomarkers, Tumor
CD8-Positive T-Lymphocytes--immunology
Cell Line, Tumor
Combined Modality Therapy
Disease Models, Animal
Genetic Vectors--administration & dosage
Humans
Immunomodulation--drug effects
Injections, Intralesional
Lymphocytes, Tumor-Infiltrating--immunology
Male
Mice
Mice, Transgenic
Models, Biological
Neoplasms--etiology
Oncolytic Virotherapy
Oncolytic Viruses--genetics
Treatment Outcome
Tumor Microenvironment--genetics
Vaccinia virus--genetics
Xenograft Model Antitumor Assays